SALT
LAKE CITY, Oct. 26, 2022 /PRNewswire/
-- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the
"Company" or "Co-Dx"), a molecular diagnostics company with a
unique, patented platform for the development of molecular
diagnostic tests, announced today that the Company will be hosting
a booth this week at Africa Health/Medlab Africa in Johannesburg, South Africa on October 26-28, 2022.
The conference is the largest gathering of healthcare companies,
technology, products and services in the sub-Saharan region,
catering to an audience of professionals from the South African
Development Community region and around the world, including
distributors, government representatives, laboratory executives,
and purchasing/procurement managers, who attend to meet with
world-class suppliers and manufacturers.
The Company's booth will showcase Co-Diagnostics'
state-of-the-art CoPrimer™ PCR technology and infectious disease
products to conference attendees, along with its upcoming Co-Dx PCR
Home testing platform.
Additional details, including registration information, can be
found here.
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a
Utah corporation, is a molecular
diagnostics company that develops, manufactures and markets
state-of-the-art diagnostics technology. The Company's technology
is utilized for tests that are designed using the detection and/or
analysis of nucleic acid molecules (DNA or RNA). The Company also
uses its proprietary technology to design specific tests to locate
genetic markers for use in industries other than infectious disease
and license the use of those tests to specific customers.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-host-booth-at-medlab-africa-on-oct-26-28-in-south-africa-301659643.html
SOURCE Co-Diagnostics